Clinical Trial Update: Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nivolumab for nasopharyngeal cancer in patients who progressed during or after platinum-based treatment; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: RECRUITING